Back to Journals » Therapeutics and Clinical Risk Management » Volume 16

Managing Disease-Modifying Therapies and Breakthrough Activity in Multiple Sclerosis Patients During the COVID-19 Pandemic: Toward an Optimized Approach

Total article views   HTML views PDF downloads Totals
6,127 Dovepress* 5,552+ 1,232 6,784
PubMed Central* 575 223 798
Totals 6,127 1,455 7,582
*Since 22 July 2020
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 1 3

View citations on PubMed Central and Google Scholar